G S S Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-06-2024
- Paid Up Capital ₹ 0.10 M
as on 18-06-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 18-06-2024
- Satisfied Charges ₹ 8.31 M
as on 18-06-2024
- Revenue 48.19%
(FY 2022)
- Profit 4.24%
(FY 2022)
- Ebitda 12.51%
(FY 2022)
- Net Worth 45.97%
(FY 2022)
- Total Assets 23.11%
(FY 2022)
About G S S Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.00 Cr. The company has closed loans amounting to ₹8.31 M, as per Ministry of Corporate Affairs (MCA) records.
Kongarahalli Nagaraja and Geethanjali Chandrareddy serve as directors at the Company.
- CIN/LLPIN
U51102KA2015PTC082095
- Company No.
082095
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Whitefield, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does G S S Pharma Private Limited offer?
G S S Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Tablets & Capsules, Cardiovascular Drugs & Medication, Cholesterol Medicine, Diabetes Medicine, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Antianginal Drugs.
Who are the key members and board of directors at G S S Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kongarahalli Nagaraja  | Director | 07-Aug-2015 | Current |
| Geethanjali Chandrareddy | Director | 07-Aug-2015 | Current |
Financial Performance of G S S Pharma.
G S S Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.19% increase. The company also saw a slight improvement in profitability, with a 4.24% increase in profit. The company's net worth Soared by an impressive increase of 45.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of G S S Pharma?
In 2022, G S S Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medford Pharmaceuticals LlpActive 6 years 4 daysKongarahalli Nagaraja and Geethanjali Chandrareddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Oct 2020 | ₹2.00 Cr | Open |
Hdfc Bank Limited Creation Date: 20 Mar 2019 | ₹4.81 M | Satisfied |
Others Creation Date: 25 Oct 2018 | ₹3.50 M | Satisfied |
How Many Employees Work at G S S Pharma?
G S S Pharma has a workforce of 23 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of G S S Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G S S Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
